Vertex Pharmaceuticals Inc. buy SVB Leerink LLC
Start price
25.09.25
/
50%
€330.00
Target price
25.09.26
€388.33
Performance (%)
16.97%
Price
01.04.26
€386.00
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC currently has a performance of 16.97%. This prediction currently runs until 25.09.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.956% | -1.956% |
| iShares Core DAX® | 1.604% | -7.448% |
| iShares Nasdaq 100 | -0.734% | -1.864% |
| iShares Nikkei 225® | 1.296% | -6.795% |
| iShares S&P 500 | -0.394% | -2.336% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $456.00 price target on the stock, down previously from $458.00.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€393.15
29.12.25
29.12.25
€445.67
29.12.26
29.12.26
-1.82%
01.04.26
01.04.26
